Automated Lugano Metabolic Response Assessment in 18F-Fluorodeoxyglucose-Avid Non-Hodgkin Lymphoma With Deep Learning on 18F-Fluorodeoxyglucose-Positron Emission Tomography

被引:8
作者
Jemaa, Skander [1 ]
Ounadjela, Souhila [1 ]
Wang, Xiaoyong [1 ]
El-Galaly, Tarec C. [2 ,3 ,4 ,5 ]
Kostakoglu, Lale [6 ]
Knapp, Andrea [7 ]
Ku, Grace [1 ]
Musick, Lisa [1 ]
Sahin, Denis [7 ]
Wei, Michael C. [1 ]
Yin, Shen [1 ]
Bengtsson, Thomas [8 ]
De Crespigny, Alex [1 ]
Carano, Richard A. D. [1 ]
机构
[1] Genentech Inc, South San Francisco, CA 94080 USA
[2] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark
[3] Odense Univ Hosp, Dept Hematol, Hematol Res Unit, Odense, Denmark
[4] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[5] AI Sweden, Lund, Sweden
[6] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA
[7] F Hoffmann La Roche, Basel, Switzerland
[8] Univ Calif Berkeley, Dept Stat, Berkeley, CA USA
关键词
ARTIFICIAL-INTELLIGENCE; LUNG-CANCER; PET/CT; DLBCL; CONSENSUS; CRITERIA;
D O I
10.1200/JCO.23.01978
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE Artificial intelligence can reduce the time used by physicians on radiological assessments. For F-18-fluorodeoxyglucose-avid lymphomas, obtaining complete metabolic response (CMR) by end of treatment is prognostic. METHODS Here, we present a deep learning-based algorithm for fully automated treatment response assessments according to the Lugano 2014 classification. The proposed four-stage method, trained on a multicountry clinical trial (ClinicalTrials.gov identifier: NCT01287741) and tested in three independent multicenter and multicountry test sets on different non-Hodgkin lymphoma subtypes and different lines of treatment (ClinicalTrials.gov identifiers NCT02257567, NCT02500407; 20% holdout in ClinicalTrials.gov identifier NCT01287741), outputs the detected lesions at baseline and follow-up to enable focused radiologist review. RESULTS The method's response assessment achieved high agreement with the adjudicated radiologic responses (eg, agreement for overall response assessment of 93%, 87%, and 85% in ClinicalTrials.gov identifiers NCT01287741, NCT02500407, and NCT02257567, respectively) similar to inter-radiologist agreement and was strongly prognostic of outcomes with a trend toward higher accuracy for death risk than adjudicated radiologic responses (hazard ratio for end of treatment by-model CMR of 0.123, 0.054, and 0.205 in ClinicalTrials.gov identifiers NCT01287741, NCT02500407, and NCT02257567, compared with, respectively, 0.226, 0.292, and 0.272 for CMR by the adjudicated responses). Furthermore, a radiologist review of the algorithm's assessments was conducted. The radiologist median review time was 1.38 minutes/assessment, and no statistically significant differences were observed in the level of agreement of the radiologist with the model's response compared with the level of agreement of the radiologist with the adjudicated responses. CONCLUSION These results suggest that the proposed method can be incorporated into radiologic response assessment workflows in cancer imaging for significant time savings and with performance similar to trained medical experts.
引用
收藏
页码:2966 / 2977
页数:13
相关论文
共 54 条
[1]   FDG-PET/CT in Lymphoma: Where Do We Go Now? [J].
Al Tabaa, Yassine ;
Bailly, Clement ;
Kanoun, Salim .
CANCERS, 2021, 13 (20)
[2]  
[Anonymous], Good machine learning practice for medical device development: Guiding principles-Canada.ca n.d
[3]   FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas [J].
Barrington, Sally F. ;
Kluge, Regine .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 :S97-S110
[4]   Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group [J].
Barrington, Sally F. ;
Mikhaeel, N. George ;
Kostakoglu, Lale ;
Meignan, Michel ;
Hutchings, Martin ;
Mueeller, Stefan P. ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Fisher, Richard I. ;
Trotman, Judith ;
Hoekstra, Otto S. ;
Hicks, Rodney J. ;
O'Doherty, Michael J. ;
Hustinx, Roland ;
Biggi, Alberto ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3048-+
[5]   Predicting cancer outcomes with radiomics and artificial intelligence in radiology [J].
Bera, Kaustav ;
Braman, Nathaniel ;
Gupta, Amit ;
Velcheti, Vamsidhar ;
Madabhushi, Anant .
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (02) :132-146
[6]   Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study [J].
Budde, Lihua E. ;
Sehn, Laurie H. ;
Matasar, Matthew ;
Schuster, Stephen J. ;
Assouline, Sarit ;
Giri, Pratyush ;
Kuruvilla, John ;
Canales, Miguel ;
Dietrich, Sascha ;
Fay, Keith ;
Ku, Matthew ;
Nastoupil, Loretta ;
Cheah, Chan Yoon ;
Wei, Michael C. ;
Yin, Shen ;
Li, Chi-Chung ;
Huang, Huang ;
Kwan, Antonia ;
Penuel, Elicia ;
Bartlett, Nancy L. .
LANCET ONCOLOGY, 2022, 23 (08) :1055-1065
[7]   Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study [J].
Budde, Lihua E. ;
Assouline, Sarit ;
Sehn, Laurie H. ;
Schuster, Stephen J. ;
Yoon, Sung-Soo ;
Yoon, Dok Hyun ;
Matasar, Matthew J. ;
Bosch, Francesc ;
Kim, Won Seog ;
Nastoupil, Loretta J. ;
Flinn, Ian W. ;
Shadman, Mazyar ;
Diefenbach, Catherine ;
O'Hear, Carol ;
Huang, Huang ;
Kwan, Antonia ;
Li, Chi-Chung ;
Piccione, Emily C. ;
Wei, Michael C. ;
Yin, Shen ;
Bartlett, Nancy L. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (05) :481-+
[8]   Deep-Learning 18F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma [J].
Capobianco, Nicolo ;
Meignan, Michel ;
Cottereau, Anne-Segolene ;
Vercellino, Laetitia ;
Sibille, Ludovic ;
Spottiswoode, Bruce ;
Zuehlsdorff, Sven ;
Casasnovas, Olivier ;
Thieblemont, Catherine ;
Buvat, Irene .
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (01) :30-36
[9]   Follicular lymphoma [J].
Carbone, Antonino ;
Roulland, Sandrine ;
Gloghini, Annunziata ;
Younes, Anas ;
von Keude, Gottfried ;
Lopez-Guillermo, Armando ;
Fitzgibbons, Jude .
NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
[10]   Medical artificial intelligence is as much social as it is technological [J].
Carusi, Annamaria ;
Winter, Peter D. D. ;
Armstrong, Iain ;
Ciravegna, Fabio ;
Kiely, David G. G. ;
Lawrie, Allan ;
Lu, Haiping ;
Sabroe, Ian ;
Swift, Andy .
NATURE MACHINE INTELLIGENCE, 2023, 5 (02) :98-100